Cargando…
Two‐year outcomes of the ARTISAN‐SNM study for the treatment of urinary urgency incontinence using the Axonics rechargeable sacral neuromodulation system
AIMS: Sacral neuromodulation (SNM) is a guideline‐recommended treatment with proven therapeutic benefit for urinary urgency incontinence (UUI) patients. The Axonics® System is the first Food and Drug Administration‐approved rechargeable SNM system and is designed to deliver therapy for a minimum of...
Autores principales: | Pezzella, Andrea, McCrery, Rebecca, Lane, Felicia, Benson, Kevin, Taylor, Chris, Padron, Osvaldo, Blok, Bertil, de Wachter, Stefan, Gruenenfelder, Jennifer, Pakzad, Mahreen, Perrouin‐Verbe, Marie‐Aimee, van Kerrebroeck, Philip, Mangel, Jeffrey, Peters, Kenneth, Kennelly, Michael, Shapiro, Andrew, Lee, Una, Comiter, Craig, Mueller, Margaret, Goldman, Howard B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986436/ https://www.ncbi.nlm.nih.gov/pubmed/33508155 http://dx.doi.org/10.1002/nau.24615 |
Ejemplares similares
-
One‐year outcomes of the ARTISAN‐SNM study with the Axonics System for the treatment of urinary urgency incontinence
por: Benson, Kevin, et al.
Publicado: (2020) -
Two‐year safety and efficacy outcomes for the treatment of overactive bladder using a long‐lived rechargeable sacral neuromodulation system
por: Blok, Bertil, et al.
Publicado: (2020) -
Oxybutynin: an overview of the available formulations
por: McCrery, Rebecca J, et al.
Publicado: (2006) -
A prospective, multicenter, international study to explore the effect of three different amplitude settings in female subjects with urinary urge incontinence receiving interstim therapy
por: Elterman, Dean, et al.
Publicado: (2021) -
Message from SNM President
por: Mittal, BR
Publicado: (2010)